ASAlbert Einstein Coutinho dos Santos Santos

Albert Einstein Coutinho dos Santos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Albert Einstein Coutinho dos Santos Santos has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Network Selection in B5G Heterogeneous Networks Using AHP-TOPSIS

    by Albert Einstein Coutinho Dos Santos, Matheus Gabriel Gomes Pantoja, Ermínio Augusto Ramos da Paixão, Reyso Cunha Teixeira, Marcos César da Rocha Seruffo, Diego Lisboa Cardoso

    The implementation of ultra-dense heterogeneous networks (HetNets) has become crucial to meet the increasing demands of 5G and beyond networks. These networks face complex challenges due to the proliferation of mobile devices, network overlay, and high mobility. In this context, it is essential to identify the most suitable network for a given user, taking into consideration the user’s specific requirements. This article proposes a multi-criteria method for dynamic and personalized network selection in the context of different technologies, highlighting the difficulty involved in deciding which access technology the user should connect to. The proposed model showed better performance for high QoS (Quality of Service) profiles and low energy consumption, and it facilitated a more efficient distribution of network resources considering the network load criterion. A comparison with another current method in the literature highlighted the efficiency of the proposed model in achieving improvements for all user profiles considered.

  • Open Access

    Model for predicting drug resistance based on the clinical profile of tuberculosis patients using machine learning techniques

    by Igor Wenner Silva Falcao, Diego Lisboa Cardoso, Albert Einstein Coutinho dos Santos Santos, Erminio Paixao, Fernando Augusto R. Costa, Karla Figueiredo, Saul Carneiro, Marcos César da Rocha Seruffo

    Tuberculosis (TB) is a disease caused by the bacterium Mycobacterium tuberculosis and despite effective treatments, still affects millions of people worldwide. The advent of new treatments has not eliminated the significant challenge of TB drug resistance. Repeated and inadequate exposure to drugs has led to the development of strains of the bacteria that are resistant to conventional treatments, making the eradication of the disease even more complex. In this context, it is essential to seek more effective approaches to fighting TB. This article proposes a model for predicting drug resistance based on the clinical profile of TB patients, using machine learning techniques. The model aims to optimize the work of health professionals directly involved with tuberculosis patients, driving the creation of new containment strategies and preventive measures, as it specifies the clinical data that has the greatest impact and identifies the individuals with the greatest predisposition to develop resistance to anti-tuberculosis drugs. The results obtained show, in one of the scenarios, a probability of development of 70% and an accuracy of 84.65% for predicting drug resistance.